Q&A
Making the Most of Your BLUE KNIGHT™ and JLABS Mentorship
Q&A
BEYOND THE BIOTECH: 7 Hills Pharma, A JLABS @ TMC and BLUE KNIGHT™ Company
Articles
From South Korea to NYC: How One Company is Establishing a Global Presence to Develop RNA-Based Therapeutics for Alzheimer’s Disease and Other Neurodegenerative Diseases
Articles
JLABS @ NYC 3rd Anniversary Milestones: Growing the Greater New York Life Science Community
Q&A
From Galway to San Diego: ONK Therapeutics’ Aim to Usher in A New Era of Engineered NK Cell Therapies with the Goal to Ultimately Cure Cancer
Articles
Celebrating Pride Month and our LGBTQ+ Innovators and Team Members!
Q&A
Meet JLABS @ NYC Resident CJ Wilson, CEO/Founder MyHealth.Us
Q&A
BEYOND THE BIOTECH: Persephone Biosciences, A JLABS @ San Diego and BLUE KNIGHT™ Company
Q&A
Johnson & Johnson Innovation – JLABS Q&A Profile – Dusan Bogunovic, Lab 11
Articles
We’re Open for Business! A First Sneak Peek of JLABS @ Washington, DC
Q&A
Problem Solvers by Nature: How Digital Proteomics is Using Bioinformatics with the Aim to Unlock the Power of the Human Immune System
Q&A
Taking RNA Therapeutics to New Heights: DTx Pharma’s Approach for Targeting Underutilized Cells and Organ Systems
Q&A
BEYOND THE BIOTECH: Alain Vicari, CEO, Calyspo Biotech JLABS @ BE Company
Articles
JLABS @ TMC Celebrates 5 Years: From the Pages of Our Scrapbook
Articles